Trial Outcomes & Findings for Effect of Varied Outreach Methods on Appointment Scheduling and Appointment Completion Using MyChart (NCT NCT04994691)

NCT ID: NCT04994691

Last Updated: 2024-08-28

Results Overview

Participants completed well child check visit as determined by presence of a well visit billing code documentation in the electronic health record.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

945 participants

Primary outcome timeframe

Within 8 weeks of the date of intervention or the date of randomization for the control group

Results posted on

2024-08-28

Participant Flow

Participant milestones

Participant milestones
Measure
No Message
No message sent No Message: No messages are sent
Standard Message
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Overall Study
STARTED
315
315
315
Overall Study
COMPLETED
315
315
315
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effect of Varied Outreach Methods on Appointment Scheduling and Appointment Completion Using MyChart

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
No Message
n=315 Participants
No message sent No Message: No messages are sent
Standard Message
n=315 Participants
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
n=315 Participants
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Total
n=945 Participants
Total of all reporting groups
Age, Customized
6-8y
137 Participants
n=5 Participants
133 Participants
n=7 Participants
134 Participants
n=5 Participants
404 Participants
n=4 Participants
Age, Customized
9-11y
96 Participants
n=5 Participants
98 Participants
n=7 Participants
98 Participants
n=5 Participants
292 Participants
n=4 Participants
Age, Customized
12-14y
33 Participants
n=5 Participants
40 Participants
n=7 Participants
38 Participants
n=5 Participants
111 Participants
n=4 Participants
Age, Customized
15-17y
49 Participants
n=5 Participants
44 Participants
n=7 Participants
45 Participants
n=5 Participants
138 Participants
n=4 Participants
Sex: Female, Male
Female
174 Participants
n=5 Participants
152 Participants
n=7 Participants
167 Participants
n=5 Participants
493 Participants
n=4 Participants
Sex: Female, Male
Male
141 Participants
n=5 Participants
163 Participants
n=7 Participants
148 Participants
n=5 Participants
452 Participants
n=4 Participants
Race/Ethnicity, Customized
Black or African American Non-Hispanic
211 Participants
n=5 Participants
184 Participants
n=7 Participants
195 Participants
n=5 Participants
590 Participants
n=4 Participants
Race/Ethnicity, Customized
White Non-Hispanic
71 Participants
n=5 Participants
82 Participants
n=7 Participants
73 Participants
n=5 Participants
226 Participants
n=4 Participants
Race/Ethnicity, Customized
Multiracial Non-Hispanic
15 Participants
n=5 Participants
21 Participants
n=7 Participants
15 Participants
n=5 Participants
51 Participants
n=4 Participants
Race/Ethnicity, Customized
Missing Data Hispanic
5 Participants
n=5 Participants
6 Participants
n=7 Participants
11 Participants
n=5 Participants
22 Participants
n=4 Participants
Race/Ethnicity, Customized
Asian Non-Hispanic
5 Participants
n=5 Participants
10 Participants
n=7 Participants
4 Participants
n=5 Participants
19 Participants
n=4 Participants
Race/Ethnicity, Customized
White Hispanic
3 Participants
n=5 Participants
5 Participants
n=7 Participants
10 Participants
n=5 Participants
18 Participants
n=4 Participants
Race/Ethnicity, Customized
Missing Data Non-Hispanic
1 Participants
n=5 Participants
3 Participants
n=7 Participants
3 Participants
n=5 Participants
7 Participants
n=4 Participants
Race/Ethnicity, Customized
Black or African American Hispanic
2 Participants
n=5 Participants
3 Participants
n=7 Participants
1 Participants
n=5 Participants
6 Participants
n=4 Participants
Race/Ethnicity, Customized
Multiracial Hispanic
1 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
3 Participants
n=4 Participants
Race/Ethnicity, Customized
American Indian and Alaska Native Non-Hispanic
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Race/Ethnicity, Customized
Middle Eastern Non-Hispanic
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Race/Ethnicity, Customized
Native Hawaiian and Other Pacific Islander Hispanic
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants

PRIMARY outcome

Timeframe: Within 8 weeks of the date of intervention or the date of randomization for the control group

Participants completed well child check visit as determined by presence of a well visit billing code documentation in the electronic health record.

Outcome measures

Outcome measures
Measure
No Message
n=315 Participants
No message sent No Message: No messages are sent
Standard Message
n=315 Participants
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
n=315 Participants
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Number of Participants Who Completed Well Child Check Visit
40 Participants
76 Participants
61 Participants

SECONDARY outcome

Timeframe: Within 8 weeks of the date of intervention or the date of randomization for the control group

Participant scheduled a well child check visit as determined by electronic health record documentation.

Outcome measures

Outcome measures
Measure
No Message
n=315 Participants
No message sent No Message: No messages are sent
Standard Message
n=315 Participants
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
n=315 Participants
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Number of Participants Who Scheduled an Appointment for a Well Child Check Visit.
30 Participants
58 Participants
47 Participants

SECONDARY outcome

Timeframe: Within 8 weeks of the date of the intervention or the date of randomization for the control group

Participant receipt of their first COVID-19 vaccination as determined by presence of documentation of vaccine administration in the electronic health record.

Outcome measures

Outcome measures
Measure
No Message
n=82 Participants
No message sent No Message: No messages are sent
Standard Message
n=84 Participants
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
n=83 Participants
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Number of Participants Who Received Their First COVID-19 Vaccination
3 Participants
14 Participants
4 Participants

POST_HOC outcome

Timeframe: Within 8 weeks of the date of intervention or the date of randomization for the control group

Population: Analysis includes all patients eligible to receive this vaccine during the 8-week study period

Participant receipt of DTaP vaccination as determined by presence of documentation of vaccine administration in the electronic health record.

Outcome measures

Outcome measures
Measure
No Message
n=32 Participants
No message sent No Message: No messages are sent
Standard Message
n=32 Participants
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
n=34 Participants
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Number of Participants Who Received DTaP Vaccination
8 Participants
6 Participants
6 Participants

POST_HOC outcome

Timeframe: Within 8 weeks of the date of intervention or the date of randomization for the control group

Population: Analysis includes all patients eligible to receive this vaccine during the 8-week study period

Participant receipt of HPV vaccination as determined by presence of documentation of vaccine administration in the electronic health record.

Outcome measures

Outcome measures
Measure
No Message
n=50 Participants
No message sent No Message: No messages are sent
Standard Message
n=49 Participants
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
n=52 Participants
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Number of Participants Who Received HPV Vaccination
7 Participants
13 Participants
9 Participants

POST_HOC outcome

Timeframe: Within 8 weeks of the date of intervention or the date of randomization for the control group

Population: Analysis includes all patients eligible to receive this vaccine during the 8-week study period

Participant receipt of MCV4 vaccination as determined by presence of documentation of vaccine administration in the electronic health record.

Outcome measures

Outcome measures
Measure
No Message
n=49 Participants
No message sent No Message: No messages are sent
Standard Message
n=54 Participants
2 MyChart reminders that child is overdue for well child check visit Standard message: 2 MyChart reminders that child is overdue for well child check visit
Tailored Message
n=57 Participants
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Number of Participants Who Received MCV4 Vaccination
9 Participants
10 Participants
12 Participants

Adverse Events

No Message

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Message

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Tailored Message

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. William B. Brinkman

Cincinnati Children's

Phone: 513-636-2576

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place